Clinical and pharmacological features of the treatment of patients with pathology of the cardiovascular system

Abstract

Post-convulsant myocarditis is one of the most common complications of the cardiovascular system of the SARS-Cov-2 virus, which has become a pandemic in the world and there may be an increase in myocarditis after this infection These are the remaining 4 years. To discover different approaches to therapy for this pathology. Post-covid myocarditis is predicted to form acute or chronic heart failure.Therefore, the improvement of the function of cardiomyocytes in the context of effective and safe pharmacotherapy and the reduction of the risk of heart failure is of great practical importance for ensuring people’s social life and reducing the risk of Invalidation of this category of patients. There is data on the use of magnesium and quercetin preparations in cardiology in patients with heart pathology. The important tasks of current pharmacology include the search for a medicinal infusion to identify the damage. This meant the choice of topics and the relevance of this work.